Harlem Biospace Fellows
Harlem Biospace Fellows are consultants to the community of companies here at Hb and contribute to both the technical design of products and the creation of business strategy. The current group ranges from biotechnology undergraduate students eager to carry out routine work to experienced healthcare consultants and postdoctoral researchers who can bring valuable perspective to the table. In return, Fellows are given access to training events and gain operational experience useful to finding a full-time opportunity in early stage biotech.
To become a Fellow, please email firstname.lastname@example.org and we will get back to you with any available opportunities.
The current cohort of Hb Fellows includes:
Shantenu has been growing ideas into products and companies for the past decade. A bioengineer by training, Shantenu has co-founded two health tech startups, worked at a healthcare focused venture capital fund, and managed corporate business development for a large Fortune 500 company across the world. His role as a Product Manager in an Artificial Intelligence company coupled with his experience in innovating and building allows him to assist inventors/co-founders think strategically through ideas, markets, and scale.
Yinka is a Vice President in Healthcare Investment Banking at Loop Capital Markets. He focuses on advisory, licensing and capital raising for life science companies, and has both buy-side and sell-side deal experiences in licensing, cross border M&A, private capital raises (for clinical stage life science companies), and debt/equity capital markets issuance (for large cap companies). He previously worked in Citigroup’s Global Healthcare Group and in Investment Banking at Santander. Yinka received his M.B.A. from Duke University’s Fuqua School of Business, and B.B.A. from the University of Georgia.
Mona is a Healthcare Analytics Manager at Milliman, where she provides data analytics and consulting services to a broad range of healthcare clients, including payers, providers, biopharmaceutical companies, and device manufacturers. Mona is experienced in analyzing and presenting findings from large data sets (e.g. Truven Health Analytics MarketScan® Research Database, CMS' Standard Analytic Files, proprietary client data) for population health studies, cost effectiveness analyses, and internal financial reporting. Prior to joining Milliman, Mona worked at Goldman Sachs as a senior analyst for the CFO of the Investment Management Division, where she conducted revenue and P&L forecasting, scenario analysis, and competitor reviews. She received a B.S. in Biological Engineering with a minor in Business from Cornell University, and a M.B.A. with a concentration in Business Analytics from NYU Stern.
Morgan is a member of the Corporate Development team at Axel Johnson, a private investment firm with holdings in the medical technology industry, among others. She is involved in sourcing investment opportunities, executing deal processes and managing strategic and operational projects to promote growth of companies in the portfolio. She is passionate about supporting the development of the life sciences sector and works closely with HighRes Biosolutions, a designer and manufacturer of laboratory automation systems used in drug discovery efforts. Morgan holds a B.S. in Biomedical Engineering from Yale University.
André is a health policy and strategy consultant at Manatt Health Strategies, where he focuses on life sciences companies, provider organizations, and digital health capabilities. He is passionate about advancing New York City's biotechnology and digital health ecosystems. André has worked across several health care functions, including government affairs and policy at Pfizer, biotechnology equity research at T. Rowe Price, business development at Novartis, and technology transfer and commercialization at Johns Hopkins University. He received a B.S. in Biology with minors in Global Health and Business from UC San Diego, and a M.S.P.H. in Health Policy from the Johns Hopkins Bloomberg School of Public Health.
Chirag Raval, PH.D.
Chirag is a passionate problem solver and start-up co-founder focused on extending human longevity by harnessing nature at the nanoscale. He serves as an educator at the City University of New York and leverages his extensive experience in chemical and biomolecular engineering to cultivate the NYC life science ecosystem as a research scholar and public health advocate. Chirag applies his experience in design, regulatory strategy and commercial development of biomedical enterprises with Hb member companies.
Farhana received her PhD in Medicinal and Pharmaceutical Chemistry from Virginia Commonwealth University, where she studied addiction mechanisms of drugs targeting monoamine transporters. She is currently a Post-Doctoral research fellow at Mount Sinai, where she studies novel therapeutic targets for treating chronic pain and comorbidities related to chronic pain such as depression and addiction. Farhana has experience in evaluating pharmaceuticals from both a market and technical perspective. She has experience making informed risk and investment recommendations with influential organizations such as the Alzheimer’s Drug Discovery Foundation and the Solution Lab.
Tiffany is a Consulting Senior Analyst in the Consulting Development Program (CDP) at Accenture. She is passionate about Insight Driven Health in the Life Sciences industry to drive evidence-based patient outcomes. Tiffany uses her skills in machine learning, data analytics, biomedical and market research, and business development to address the latest challenges in medical diagnostics. Her previous experience includes a Strategy role in Johnson & Johnson's pharma sector and an opportunity to work at TEDMED, the health and medicine edition of TED. In addition to her business skills, she has a Bachelor's in Biomedical Engineering from Columbia University, where she built her technical foundation in biomedical research, particularly in biomedical imaging.